These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11356936)
1. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. Banks WA; Farr SA; Butt W; Kumar VB; Franko MW; Morley JE J Pharmacol Exp Ther; 2001 Jun; 297(3):1113-21. PubMed ID: 11356936 [TBL] [Abstract][Full Text] [Related]
2. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor. Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986 [TBL] [Abstract][Full Text] [Related]
3. Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. Erickson MA; Niehoff ML; Farr SA; Morley JE; Dillman LA; Lynch KM; Banks WA J Alzheimers Dis; 2012; 28(4):951-60. PubMed ID: 22179572 [TBL] [Abstract][Full Text] [Related]
4. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease. Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021 [TBL] [Abstract][Full Text] [Related]
5. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399 [TBL] [Abstract][Full Text] [Related]
6. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. Lee CL; Kuo TF; Wang JJ; Pan TM J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476 [TBL] [Abstract][Full Text] [Related]
7. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin enhances learning and memory independent of amyloid load in mice. Li L; Cao D; Kim H; Lester R; Fukuchi K Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930 [TBL] [Abstract][Full Text] [Related]
9. Effects of leptin on memory processing. Farr SA; Banks WA; Morley JE Peptides; 2006 Jun; 27(6):1420-5. PubMed ID: 16293343 [TBL] [Abstract][Full Text] [Related]
10. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673 [TBL] [Abstract][Full Text] [Related]
11. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404 [TBL] [Abstract][Full Text] [Related]
12. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209 [TBL] [Abstract][Full Text] [Related]
13. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
15. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024 [TBL] [Abstract][Full Text] [Related]
16. DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice. Farr SA; Banks WA; Uezu K; Gaskin FS; Morley JE Life Sci; 2004 Oct; 75(23):2775-85. PubMed ID: 15464829 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
19. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response. Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]